Oramed Pharmaceuticals
ORMP
ORMP
28 hedge funds and large institutions have $8.45M invested in Oramed Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
8.2% more ownership
Funds ownership: 1.83% → 10.03% (+8.2%)
0% more call options, than puts
Call options by funds: $4K | Put options by funds: $4K
Holders
28
Holding in Top 10
1
Calls
$4K
Puts
$4K
Top Buyers
| 1 | +$3.88M | |
| 2 | +$3.04M | |
| 3 | +$88K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$82K |
| 5 |
Squarepoint
New York
|
+$71K |
Top Sellers
| 1 | -$59.7K | |
| 2 | -$24.9K | |
| 3 | -$5K | |
| 4 |
LC
Landaas & Company
Milwaukee,
Wisconsin
|
-$2K |
| 5 |
Morgan Stanley
New York
|
-$24 |